They do not predict response to any specific medication, but they do frame the starting point that no price sheet mentions
Diabetes management in chronic kidney disease: a consensus report by the American diabetes association (ADA) and kidney disease: improving global outcomes (KDIGO)
Any symptoms suggesting thyroid hormone imbalancesuch as new or worsening fatigue, palpitations, heat or cold intolerance, or changes in weight beyond expected GLP-1 effectsshould prompt thyroid function testing and clinical reassessment
Strategic positioning: in this setting, GLP-1RAs are best positioned as adjunct metabolic optimization to improve the response to standard OI, rather than as substitutes for OI
Both Mounjaro and Wegovy are effective for weight management, but individual results vary
Schedule your appointment with me online (link in bio) for your B12 injection